Literature DB >> 8194754

The ARG4 gene of Candida albicans.

L L Hoyer1, B B Magee, E H Rikkerink, S Scherer.   

Abstract

The DNA sequence of a Candida albicans genomic fragment known to complement the arginine mutation designated arg57 in strain 1006 contains an ORF of 1404 nucleotides (nt) predicting a protein of 468 amino acids (aa). Database searches indicated that the deduced protein shares 75% identity and 85% similarity with the ARG4 protein of Saccharomyces cerevisiae. Analysis of the percent aa identity between C. albicans and S. cerevisiae sequences included in available databases suggested these values are within the range expected for biosynthetic enzymes from the two organisms which share similar function. Experiments to isolate C. albicans ARG4 by complementation in an arg4 strain of S. cerevisiae yielded a plasmid (pARG4-1) with a restriction map identical to that of the sequenced clone. From these data, we conclude that the gene previously designated ARG57 is in fact ARG4 encoding the enzyme argininosuccinate lyase (ASL). These results were unexpected, since ARG57 had been localized to chromosome 7, while a mutation causing an ASL deficiency had been linked to ade1, which is on chromosome R. Transformation of C. albicans strains with pARG4-1 indicated it complemented the arginine auxotrophy in strains TMSU221 and 1435, a derivative of 1006. Examination of commonly utilized C. albicans arginine auxotrophs by spheroplast fusion analysis indicated these strains comprise two complementation groups: one consisting of 1006 and TMSU221, which are arg4, and the other of A642, hOG318, hOG357, FC18-6 and WC-5-4, which possess an undefined defect in the arginine biosynthetic pathway which we designate arg100.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194754     DOI: 10.1016/0378-1119(94)90263-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans.

Authors:  D Andes; A Forrest; A Lepak; J Nett; K Marchillo; L Lincoln
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

2.  Single-copy IMH3 allele is sufficient to confer resistance to mycophenolic acid in Candida albicans and to mediate transformation of clinical Candida species.

Authors:  J Beckerman; H Chibana; J Turner; P T Magee
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Lack of consistent short sequence repeat polymorphisms in genetically homologous colonizing and invasive Candida albicans strains.

Authors:  F V Lunel; L Licciardello; S Stefani; H A Verbrugh; W J Melchers; J F Meis; S Scherer; A van Belkum
Journal:  J Bacteriol       Date:  1998-08       Impact factor: 3.490

4.  A physical map of chromosome 7 of Candida albicans.

Authors:  H Chibana; B B Magee; S Grindle; Y Ran; S Scherer; P T Magee
Journal:  Genetics       Date:  1998-08       Impact factor: 4.562

5.  Multidrug resistance in Candida albicans: disruption of the BENr gene.

Authors:  M Goldway; D Teff; R Schmidt; A B Oppenheim; Y Koltin
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.